Mortality reduction by implantable Cardioverter-Defibrillators in patients with Ischemic Heart Disease, Congestive Heart Failure, and Ventricular Arrhythmias

被引：0
|
作者：
Chan, P [1 ]
Hayward, R [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2360
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [21] Weather and triggering of ventricular arrhythmias in patients with implantable cardioverter-defibrillators
    Jennifer L Nguyen
    Francine Laden
    Mark S Link
    Joel Schwartz
    Heike Luttmann-Gibson
    Douglas W Dockery
    Journal of Exposure Science & Environmental Epidemiology, 2015, 25 : 175 - 181
  • [22] Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
    Spartalis, Michael
    Iliopoulos, Dimitrios C.
    Spartalis, Eleftherios
    Athanasiou, Antonios
    Paschou, Stavroula A.
    Voudris, Vassilis
    Siasos, Gerasimos
    JOURNAL OF CARDIOLOGY, 2020, 75 (05) : 583 - 584
  • [23] Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease
    Riahi, S
    Schmidt, EB
    Christensen, JH
    Heath, F
    Pedersen, AK
    Nielsen, JC
    Molgaard, H
    Toft, E
    CARDIOLOGY, 2005, 104 (04) : 210 - 214
  • [24] System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients
    Radbill, Andrew E.
    Triedman, John K.
    Berul, Charles I.
    Fynn-Thompson, Francis
    Atallah, Joseph
    Alexander, Mark E.
    Walsh, Edward P.
    Cecchin, Frank
    HEART RHYTHM, 2010, 7 (02) : 193 - 198
  • [25] Implantable cardioverter-defibrillators, heart failure, and patient characteristics - Reply
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    Peterson, Eric D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 286 - 286
  • [26] Implantable Cardioverter-Defibrillators in Heart Transplant Recipients With Allograft Failure
    DeFilippis, Ersilia M.
    Farr, Maryjane A.
    Biviano, Angelo
    Takeda, Koji
    Topkara, Veli K.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (02) : 245 - 247
  • [27] Implantable Cardioverter-Defibrillators in Heart Transplant Recipients with Allograft Failure
    DeFilippis, E. M.
    Garan, A. R.
    Givens, R. C.
    Truby, L. K.
    Latif, F.
    Restaino, S. W.
    Takeda, K.
    Takayama, H.
    Naka, Y.
    Colombo, P. C.
    Farr, M. A.
    Topkara, V. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S286 - S287
  • [28] Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review
    Herman, Mark
    Horner, Kathryn
    Ly, Julie
    Vayl, Yelizaveta
    JOURNAL OF HOSPICE & PALLIATIVE NURSING, 2018, 20 (01) : 63 - 71
  • [29] Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators
    Gali, Wagner L.
    Sarabanda, Alvaro V.
    Baggio, Jose M., Jr.
    Silva, Eduardo F.
    Gomes, Gustavo G.
    Junqueira, Luiz F., Jr.
    EUROPACE, 2019, 21 (07): : 1070 - 1078
  • [30] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IN PATIENTS WITHOUT INDUCIBLE VENTRICULAR ARRHYTHMIAS
    WETHERBEE, JN
    TROUP, PJ
    CHAPMAN, PD
    PETERSON, PA
    THAKUR, RK
    TUCKER, VL
    VESETHROGERS, J
    ALMASSI, GH
    OLINGER, GN
    CLINICAL RESEARCH, 1989, 37 (04): : A892 - A892
12345